AngioDynamics, Inc. $ANGO Shares Acquired by Divisadero Street Capital Management LP

Key Points

• Divisadero Street Capital Management LP increased its stake in AngioDynamics by 8.3% in Q3, buying 282,695 shares to hold 3,678,125 shares (about 8.93% of the company) valued at roughly $41.09 million, making ANGO its 14th-largest holding and 1.8% of the fund's portfolio.
• Analysts are mixed but the consensus rating is a "Moderate Buy" with an average price target of $19.33, versus a recent open of $10.60, implying significant upside despite individual ratings ranging from Strong Buy to Sell.
• Institutional ownership is high at 89.43%; AngioDynamics has a market capitalization of about $436.9 million, a negative trailing PE of -15.82, and a 12-month trading range of $8.36–$13.99.

Divisadero Street Capital Management LP increased its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 8.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,678,125 shares of the medical instruments supplier's stock after purchasing an additional 282,695 shares during the quarter. AngioDynamics accounts for 1.8% of Divisadero Street Capital Management LP's investment portfolio, making the stock its 14th biggest holding. Divisadero Street Capital Management LP owned approximately 8.93% of AngioDynamics worth $41,085,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. State of Alaska Department of Revenue acquired a new position in AngioDynamics in the 3rd quarter valued at $25,000. Washington Trust Advisors Inc. acquired a new stake in shares of AngioDynamics during the third quarter worth $27,000. State of Wyoming purchased a new stake in shares of AngioDynamics in the second quarter valued at $31,000. Russell Investments Group Ltd. increased its stake in AngioDynamics by 329.5% in the third quarter. Russell Investments Group Ltd. now owns 4,188 shares of the medical instruments supplier's stock valued at $47,000 after purchasing an additional 3,213 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in AngioDynamics by 359.0% in the second quarter. Tower Research Capital LLC TRC now owns 5,457 shares of the medical instruments supplier's stock valued at $54,000 after purchasing an additional 4,268 shares during the last quarter. Institutional investors and hedge funds own 89.43% of the company's stock.

AngioDynamics Price Performance

Shares of NASDAQ:ANGO opened at $10.60 on Monday. The business has a 50-day moving average of $10.80 and a two-hundred day moving average of $11.53. The firm has a market capitalization of $436.93 million, a PE ratio of -15.82 and a beta of 0.48. AngioDynamics, Inc. has a 12 month low of $8.36 and a 12 month high of $13.99.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Zacks Research raised AngioDynamics from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 9th. Wall Street Zen downgraded shares of AngioDynamics from a "buy" rating to a "hold" rating in a research note on Sunday, December 21st. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of AngioDynamics in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $19.33.

About AngioDynamics

AngioDynamics, Inc is a medical technology company headquartered in Latham, New York, that develops, manufactures and markets a broad range of minimally invasive medical devices. The company's products focus on three core areas: vascular access, peripheral vascular intervention and interventional oncology. Its solutions are designed to improve procedural outcomes, reduce complications and enhance patient comfort in hospital and outpatient settings.

In the vascular access segment, AngioDynamics offers a portfolio of devices including implanted ports, peripherally inserted central catheters (PICCs), hemodialysis catheters and specialty blood management products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.